Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Scrip Team

Latest From Scrip Team

Executives On The Move: Aerie Pharmaceuticals, Valeo Pharma and More

Recent executive changes in the industry include C-suite changes at ADC Therapeutics and ImmunoGen. Meanwhile, new directors were appointed at Aerie Pharmaceuticals and Adagene.

Executive Changes Leadership

Pipeline Watch: Nine Approvals And Phase III Trial Updates

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Executives On The Move: Sirnaomics, SIGA Technologies and More

Recent executive changes in the industry include C-suite changes at Sirnaomics and Horizon Therapeutics. Meanwhile, new directors were appointed at SIGA Technologies and Forte Biosciences.

Executive Changes Leadership

Pipeline Watch: 13 Approvals And 33 Phase III Trial Updates

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Clinical Trials

Pipeline Watch: 11 Approvals And 41 Phase III Updates

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Executives On The Move: Immune-Onc Therapeutics, Lipocine and More

Recent executive moves in the industry include C-suite changes at Lipocine and Actinium Pharmaceuticals. Meanwhile, new directors were appointed at Immune-Onc Therapeutics and Blue Water Vaccines.

Executive Changes Leadership
See All
UsernamePublicRestriction

Register